All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
07/13/22	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities	8
07/13/22	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Documents EX-99.1 EX-99.2	95
07/08/22	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	5
07/06/22	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions	43
07/06/22	8-K	Current report filing Documents EX-99.1 EX-99.2	43
07/05/22	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions	227
07/05/22	8-K	Current report filing Documents EX-2.1 EX-4.1 EX-4.2 EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-10.5 EX-10.6 EX-10.7 EX-99.1	227
06/07/22	8-K	Current report filing Documents EX-99.1	35
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3